Inventurus Knowl

Inventurus Knowledge Solutions Limited reported a strong Q1 FY26, with revenue reaching approximately ₹740 crores, marking a 16% year-on-year growth (13% in constant currency). The company achieved an EBITDA margin of 32%, translating to approximately ₹238 crores, which represents a 36% YoY increase. PAT grew significantly by 59% YoY to about ₹151 crores, driven by both operational efficiencies and a reduction in finance costs from ₹26 crores in Q1 FY25 to ₹18 crores in Q1 FY26. EPS stood at ₹9, up 58% YoY and 2% QoQ, with a healthy Return on Equity of 31%.

The company made significant strides in its AI-native, agentic platform strategy, launching 'Scribble Now' for fully ambient, autonomous clinical documentation. This includes a multi-variant Scribble option allowing physicians to choose different variants for different visit types. IKS also expanded its Gen AI-led autonomous medical coding technology to two specialties and is progressing in denial prediction/prevention and AI-led patient engagement. This strategic shift aims to move towards fully autonomous features, reducing reliance on human-in-the-loop models over time.

Eighteen months post-acquisition, the integration of AQuity is largely complete, with management noting that the effort 'feels complete' and synergies are evident in performance. While the transformation of AQuity's delivery model from human-led to technology-led has caused a 'material drag' on revenue per unit, it has significantly improved margins. The company's global headcount decreased by 7% YoY to 12,368 FTEs, demonstrating non-linearity in growth, as revenue increased by 16% with fewer employees.

IKS secured significant client wins, including Sky Lakes Health System for full platform adoption (ambulatory and acute RCM end-to-end), making it the second end-to-end acute RCM customer. New relationships were formed with Bicycle Health, a PE-owned behavioral health platform, and an expanded partnership with OrthoNY to a full-platform thesis. The Palomar deal, a 15-year contract, is progressing 'tremendously ahead of plan,' and the Western Washington deal, involving a $17 million investment for a 48% MSO stake and a 30-year perpetual contract, is expected to yield a +15% revenue upside.

The company's net debt continued its improving trend, standing at ₹448 crores at the end of Q1 FY26. This reduction, coupled with lower interest rates, contributed to a decrease in finance costs from ₹26 crores in Q1 FY25 to ₹18 crores in the current quarter, significantly boosting PAT growth. Operating cash flow for the quarter was ₹165 crores, with free cash flow at ₹137 crores, after accounting for a $5 million upfront performance guarantee.

Management expressed confidence in achieving EBITDA margins in the 'early to mid-30s' range, noting that the company is already past the early 30s. While the optimization of the legacy AQuity workforce is expected to continue for another two to three quarters, overall headcount is projected to 'inch up' in the rest of the year to support growth in other business areas. The Effective Tax Rate is expected to remain around 22% for the full year due to the loss of tax breaks in one SEZ unit.